ADPKD

DEER PARK, Ill., August 5, 2026 Eton Pharmaceuticals has licensed the U.S. rights to ASN-001 (timolol topical gel) from...

Glasgow, Scotland, August 5, 2026 Mironid has successfully raised $46 million in a Series B financing round to accelerate...

MONMOUTH, N.J., Sept. 18, 2025 A new investigational therapy, JD-004, has received Orphan Drug Designation (ODD) from the U.S. Food...